Want to see TSE:PINK full AI Analyst Report?
Perimeter Medical Imaging AI (PINK) Ratios
28 Followers
Perimeter Medical Imaging AI Ratios
TSE:PINK's free cash flow for Q2 2026 was C$-2.89M. For the 2026 fiscal year, TSE:PINK's free cash flow was increased by C$0.00 and operating cash flow was C$-2.89M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.56 | 2.79 | 3.36 | 3.92 | 3.60 |
| Quick Ratio | 1.53 | 2.73 | 3.34 | 3.91 | 3.60 |
| Cash Ratio | 1.17 | 1.73 | 2.02 | 3.54 | 2.20 |
| Solvency Ratio | -4.74 | -3.27 | -2.58 | -0.30 | -6.51 |
| Operating Cash Flow Ratio | -4.47 | -4.12 | -2.13 | -1.48 | -6.48 |
| Short-Term Operating Cash Flow Coverage | -155.65 | -218.68 | 0.00 | -107.52 | -77.13 |
| Net Current Asset Value | C$ 697.32K | C$ 6.10M | C$ 16.09M | C$ 23.01M | C$ 5.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.04 |
| Debt-to-Equity Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.06 |
| Debt-to-Capital Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| Financial Leverage Ratio | 1.63 | 1.37 | 1.80 | 1.33 | 1.34 |
| Debt Service Coverage Ratio | -148.22 | -135.29 | 0.00 | -25.07 | -55.26 |
| Interest Coverage Ratio | -582.58 | -717.02 | 0.00 | -153.64 | -145.49 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Net Debt to EBITDA | 0.19 | 0.48 | 0.76 | 2.40 | 0.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.09% | 63.24% | 51.15% | 75.79% | 44.45% |
| EBIT Margin | -561.57% | -1579.76% | -4646.27% | -9611.82% | -116085.45% |
| EBITDA Margin | -525.40% | -1493.53% | -4493.94% | -8826.52% | -140655.44% |
| Operating Profit Margin | -561.57% | -2210.57% | -5137.06% | -12142.65% | -141482.69% |
| Pretax Profit Margin | -560.66% | -1582.84% | -4694.58% | -7461.33% | -146802.18% |
| Net Profit Margin | -560.66% | -1582.84% | -4694.58% | -2700.97% | -147774.66% |
| Continuous Operations Profit Margin | -560.66% | -1582.84% | -4694.58% | -7461.33% | -146802.18% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 36.20% | 100.66% |
| EBT Per EBIT | 99.84% | 71.60% | 91.39% | 61.45% | 103.76% |
| Return on Assets (ROA) | -195.71% | -93.49% | -69.94% | -10.37% | -167.88% |
| Return on Equity (ROE) | -319.00% | -128.11% | -125.75% | -13.74% | -225.80% |
| Return on Capital Employed (ROCE) | -285.52% | -173.99% | -102.73% | -60.71% | -204.75% |
| Return on Invested Capital (ROIC) | -281.82% | -172.16% | -102.48% | -21.85% | -199.11% |
| Return on Tangible Assets | -195.71% | -93.49% | -69.94% | -10.37% | -167.92% |
| Earnings Yield | -45.55% | -70.95% | -24.01% | -3.61% | -9.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.91 | 0.36 | 0.17 | 0.07 | 0.00 |
| Payables Turnover | 0.78 | 0.06 | 0.09 | 0.01 | 0.00 |
| Inventory Turnover | 19.94 | 1.62 | 1.53 | 0.75 | 0.97 |
| Fixed Asset Turnover | 0.68 | 0.19 | 0.10 | 0.04 | 0.01 |
| Asset Turnover | 0.35 | 0.06 | 0.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.62 | 0.07 | 0.02 | 0.01 | 0.00 |
| Cash Conversion Cycle | -407.11 | -4377.99 | -1745.01 | -21059.79 | 376.01 |
| Days of Sales Outstanding | 40.97 | 1018.22 | 2125.36 | 5432.83 | 0.00 |
| Days of Inventory Outstanding | 18.30 | 224.78 | 238.87 | 486.98 | 376.01 |
| Days of Payables Outstanding | 466.39 | 5620.99 | 4109.24 | 26979.60 | 0.00 |
| Operating Cycle | 59.28 | 1243.00 | 2364.23 | 5919.81 | 376.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.11 | -0.21 | -0.23 | -0.20 | -0.32 |
| Free Cash Flow Per Share | -0.12 | -0.24 | -0.23 | -0.23 | -0.36 |
| Dividend Paid and CapEx Coverage Ratio | -72.19 | -6.76 | -30.97 | -5.96 | -6.56 |
| Capital Expenditure Coverage Ratio | -72.19 | -6.76 | -30.97 | -5.96 | -6.56 |
| Operating Cash Flow Coverage Ratio | -79.06 | -107.09 | -76.19 | -36.44 | -31.54 |
| Operating Cash Flow to Sales Ratio | -4.02 | -17.40 | -36.42 | -89.39 | -1226.52 |
| Free Cash Flow Yield | -33.09% | -89.53% | -19.23% | -13.94% | -8.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.19 | -1.39 | -4.16 | -27.72 | -10.79 |
| Price-to-Sales (P/S) Ratio | 12.31 | 22.31 | 195.52 | 748.76 | 15943.76 |
| Price-to-Book (P/B) Ratio | 7.00 | 1.81 | 5.24 | 3.81 | 24.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.02 | -1.12 | -5.20 | -7.17 | -11.28 |
| Price-to-Operating Cash Flow Ratio | -3.06 | -1.28 | -5.37 | -8.38 | -13.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.14 | 0.04 | -0.01 | 0.33 | -0.35 |
| Enterprise Value Multiple | -2.15 | -1.02 | -3.59 | -6.08 | -11.07 |
| Enterprise Value | 26.50M | 12.83M | 65.11M | 71.30M | 176.57M |
| EV to EBITDA | -2.15 | -1.02 | -3.59 | -6.08 | -11.07 |
| EV to Sales | 11.31 | 15.16 | 161.35 | 537.01 | 15566.54 |
| EV to Free Cash Flow | -2.78 | -0.76 | -4.29 | -5.14 | -11.01 |
| EV to Operating Cash Flow | -2.81 | -0.87 | -4.43 | -6.01 | -12.69 |
| Tangible Book Value Per Share | 0.05 | 0.15 | 0.31 | 0.43 | 0.17 |
| Shareholders’ Equity Per Share | 0.05 | 0.15 | 0.23 | 0.43 | 0.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | 0.64 | -0.01 |
| Revenue Per Share | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 |
| Net Income Per Share | -0.16 | -0.19 | -0.29 | -0.06 | -0.38 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.36 | 1.01 |
| Interest Burden | 1.00 | 1.00 | 1.01 | 0.78 | 1.26 |
| Research & Development to Revenue | 2.14 | 7.85 | 16.92 | 41.25 | 396.65 |
| SG&A to Revenue | 3.85 | 14.45 | 20.10 | 41.01 | 695.50 |
| Stock-Based Compensation to Revenue | 0.00 | 2.25 | 3.63 | 11.48 | 219.40 |
| Income Quality | 0.72 | 1.10 | 1.05 | 1.20 | 0.84 |
Currency in CAD
